Amarin to Present at Two Investor Conferences in June 2021
May 18 2021 - 6:05AM
Amarin Corporation plc (NASDAQ:AMRN) today announced that John F.
Thero, Amarin's president and chief executive officer, and Karim
Mikhail, Amarin’s senior vice president and head of commercial for
Europe and future president and chief executive officer, are
scheduled to present at the following investor conferences
scheduled in June:
- Jefferies Virtual Healthcare
Conference on Wednesday, June 2, 2021 at 9:30 a.m. Eastern
Time
- Goldman Sachs 42nd Annual Global
Healthcare Conference on Tuesday, June 8, 2021 at 10:30 a.m.
Eastern Time
Live audio webcasts of the presentations will be
available at: http://www.amarincorp.com, and will be accessible at
the same link for 30 days.
About Amarin Amarin is an
innovative pharmaceutical company leading a new paradigm in
cardiovascular disease management. From our scientific research
foundation to our focus on clinical trials, and now our commercial
expansion, we are evolving and growing rapidly. Amarin has offices
in Bridgewater, New Jersey in the United States, Dublin in Ireland,
and Zug in Switzerland as well as commercial partners and suppliers
around the world. We are committed to rethinking cardiovascular
risk through the advancement of scientific understanding of the
impact on society of significant residual risk that exists beyond
traditional therapies, such as statins for cholesterol
management.
Availability of Other Information About
AmarinInvestors and others should note that Amarin
communicates with its investors and the public using the company
website (www.amarincorp.com), the investor relations website
(investor.amarincorp.com), including but not limited to investor
presentations and investor FAQs, Securities and Exchange Commission
filings, press releases, public conference calls and webcasts. The
information that Amarin posts on these channels and websites could
be deemed to be material information. As a result, Amarin
encourages investors, the media, and others interested in Amarin to
review the information that is posted on these channels, including
the investor relations website, on a regular basis. This list of
channels may be updated from time to time on Amarin’s investor
relations website and may include social media channels. The
contents of Amarin’s website or these channels, or any other
website that may be accessed from its website or these channels,
shall not be deemed incorporated by reference in any filing under
the Securities Act of 1933.
Amarin Contact Information
Investor Inquiries:Investor RelationsAmarin
Corporation plcIR@amarincorp.com (investor inquiries)
Solebury Troutamarinir@troutgroup.com
Media Inquiries:CommunicationsAmarin Corporation
plcIn U.S.: +1 (908) 892-2028 PR@amarincorp.com (media
inquiries)
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024